Schedule a Meeting
Download Brochure
Table of Content
May 2025
The CDMO packaging market is accelerating, with forecasts predicting hundreds of millions in revenue growth between 2025 and 2034, powering sustainable infrastructure globally. This market is growing due to increased demand for pharmaceutical packaging. Pharma Companies are focusing more on the key aspects, which are the research and development of the drugs, and other activities, such as packaging and labelling, are outsourced to CDMO packaging service providers. which helps them to focus on their core operations. CDMOs also provide effective, high-quality packaging at a reasonable price, which creates a win-win situation for both pharma companies and CDMO packaging providers.
CDMO stands for contract development and manufacturing organization. It is an outsourcing pharmaceutical product packaging service that provides the packaging services as per requirements. The benefits of opting for CDMO packaging services are that they are highly specialized in packaging services, which provides quality pharmaceutical packaging solutions. They provide high-quality packaging at a very high speed. superior quality is offered due to their sophisticated equipment and packaging units. one of the key attributes about CDMO packaging services is the flexibility and scalability they offer. Small drug manufacturing companies can also utilize the CDMO packaging services, and companies that require a huge scale for drug packaging can also avail the services without requiring any on-site equipment or plant setup.
| Metric | Details |
| Leading Region | North American |
| Market Segmentation | By Type, By Application and By Region Covered |
| Top Key Players | West Pharmaceutical Services Inc., ZOIC BIOTECH PVT LTD, Schott AG, Westrock Company, Amcor plc,Catalent Pharma Solutions |
| Growth Drivers | Increased demand for pharmaceutical packaging. Pharma companies outsourcing packaging to CDMOs. Cost-effective, high-quality packaging solutions provided by CDMOs |
CDMO ensures that the ideal packaging material for a particular type of drug packaging is used. they make sure the highest quality of equipment and standard procedures are followed to maintain the product integrity. labelling and serialization responsibilities are managed by CDMO packaging services. The quality control and assurance-related responsibilities are handled by CDMO. This allows the pharmaceutical companies to save costs and have a superior quality packaging solution. CDMO allows the drug manufacturers to focus on their core work, which is the research and development of the drug, and other secondary responsibilities are handled by the CDMO packaging service provider organization
Artificial intelligence is actively changing the CDMO packaging industry by providing various features in the production, supply chain, inventory management, and decision-making regarding the demand and supply of the product. Automation in production is one of the key features that AI is bringing to the market. it is helping to achieve high-quality packaging solutions while reducing the labour cost, which is ultimately leading to a better-quality product at a cost-effective price. Rapid virtual prototypes can be built using AI, and the most effective ones can be developed according to the requirements of the specific drug.
AI working with IoT technology has introduced the smart packaging solutions, they utilize the sensors for tracking the real-time shipments, also validating the product authenticity, which helps in dealing with the product counterfeiting issue, which is highly important considering the serious effects of fake medicines in the market if undetected, it can lead to ineffective treatment or even serious results. The brand reputation can be severely spoiled due to such incidents. AI is going to be the centre point of the CDMO packaging industry.
Evolution of Modern Medical Science and Continuous Discovery of Novel Drugs
Continuous evolution of modern medical science is accelerating the development of various new drugs, which is creating the requirement for specialized and novel packaging solutions. The increasing complexity of biologics and the rising adoption of novel therapeutic modalities are leading to market growth. One of the key aspects is the increased approval of monoclonal antibodies bio bio-biosimilars, gene therapies, cell therapies, and mRNA vaccines, which require sophisticated packaging solutions.
Pharmaceutical companies have increased their dependency on CDMOs to outsource the packaging and labelling due to the high cost of in-house packaging units. the CDMOs offer high-quality packaging at cost cost-effective price while ensuring regulatory compliance and Standards, which provides a better value to the pharmaceutical companies.
Raw Material Procurement and Regulatory Challenges
The Global supply chain disruptions impact on the raw material procurement, leading to under-stocking and over-stocking, which can hamper production and create a delay. The volatility of raw material costs and labor costs also makes it difficult to maintain the standard pricing of packaging products. On a global level, every region has its customised regulations and compliances, ensuring that the packaging solution will comply with all the regulations is a challenging task to implement. The CDMO packaging market is trying to figure out solutions for these challenges using various practical and realistic approaches.
Increased Prevalence of Various Diseases Generating Pharmaceutical Products and Packaging Demands
Continuous discovery of new drugs in the pharmaceutical industry is generating huge demand for packaging solutions, and being one of the effective ways for packaging solutions, CDMO packaging is preferred by the industry because of its various benefits. one of the key benefits is the cost effectiveness, which is helping the product to be competitive in the market. The specialisation and expertise are highly demanded in the market due to the growing biologics and complex drug manufacturing processes like cell and gene therapy.
CDMOs provide high-speed production at a reasonable cost; due to this, pharma and biotech companies are choosing CDMO packaging services. Recent technological advancements and the growing market for generic medicines is also creating a huge opportunity in the CDMO packaging market. As the global generic medicine market was valued at around $389.0 billion in 2024, it will continue to grow, considering the growing population's needs.
In the CDMO packaging market, the secondary packaging segment held the largest share in 2024 due to the higher necessity of product protection during transportation, storage, and handling. One of the key aspects behind the dominance of secondary packaging is the emphasis on product marketing and packaging for visual appeal in the retail market. secondary packaging plays a crucial role in protecting the product from damage and contamination of the product. The primary packaging is the fastest growing segment as it is the first layer of packaging for the medicines and drugs, which ensures the safety and protection from external exposure like moisture, light, etc. high-quality material is used in primary packaging to avoid any reaction with the sensitive drugs stored inside.
The biopharmaceutical industry led the application segment in the CDMO packaging market in the year 2024. The primary reason behind this is the rapid growth in manufacturing requirements of biologics, monoclonal antibodies, gene therapy, and vaccines, which require highly specialised and effective packaging solutions, which is contributing heavily to the dominance of the biopharmaceutical industry segment in the CDMO packaging market. The pharmaceutical industry was the fastest-growing segment in the CDMO packaging market in 2024.
The key contributing factor in the growth of this segment is the increasing prevalence of chronic diseases, which is creating a massive requirement for healthcare and support services, which is driving the demand for medicines and drugs. Another key factor is the shifting trend of pharmaceutical companies to outsource the packaging to the CDMO companies for effective packaging at a cost-effective price.
The North American region contains a very strong establishment of research and development ecosystems in the pharmaceutical industry. Various big CDMO giants are situated in this region, which provide high-quality packaging solutions for the medicines and drugs developed in the region. The supportive facilities, such as cold chain logistics and storage facilities, are essential for the storage and transport of these highly sensitive biologics, which ensure and contribute to the dominance of the North American region in the CDMO packaging market.
Strong regulations in the North American region provide a favourable environment, such as support from the FDA, which provides necessary facilities for drug development approval and protects intellectual property rights. This region is heavily shifting towards sustainable solutions due to government regulations and demand from consumers, which is going to create a strong preference for sustainable materials for the CDMO packaging in the near future.
The demand for healthcare support and services has increased in the European region in recent times due to the increasing prevalence of chronic illnesses, which has generated demand in the CDMO packaging market. The European region is showing a preference for sustainable packaging solutions due to the EU regulations and the general public demand. Requirement for personalized medicine and transparency are generating demand in the European region CDMOs are actively looking to collaborate with companies that can provide specialized packaging solutions, such as temper proof packaging, child child-resistant designs, etc.
Asia Pacific is a region situated with countries like China and India, where China is a huge giant in material and packaging industry due to its robust manufacturing capability, and India is the hub for pharmaceuticals and CDMO packaging companies. which is driving the growth of the Asia Pacific region in the CDMO market. The region contains almost half the population of the entire world, and it has a huge requirement for medicines and drugs. which is driving the CDMO packaging market in this region, the accessibility of medical facilities is continuously increasing in Asia Pacific, which is increasing the demand for medicines and their packaging solutions. This is going to be one of the most promising regions for the CDMO packaging market in the near future due to its various factors like big population, and an aging population in countries like China and Japan.
By Type
By Application
By Region Covered
May 2025
May 2025
May 2025
May 2025
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published40+
Consulting Projects Per Year25+
Analysts